Provided by Tiger Fintech (Singapore) Pte. Ltd.

Iovance Biotherapeutics, Inc.

3.25
-0.0800-2.40%
Post-market: 3.250.00000.00%19:55 EDT
Volume:9.06M
Turnover:29.60M
Market Cap:1.07B
PE:-2.53
High:3.35
Open:3.32
Low:3.21
Close:3.33
Loading ...

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024

THOMSON REUTERS
·
08 Nov 2024

Iovance Biotherapeutics Q3 Pretax Profit USD -85.061 Million

THOMSON REUTERS
·
08 Nov 2024

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024

GlobeNewswire
·
08 Nov 2024

Iovance Biotherapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
06 Nov 2024

Iovance Biotherapeutics Price Target Maintained With a $32.00/Share by HC Wainwright & Co.

Dow Jones
·
06 Nov 2024

High Growth Tech Stocks to Watch in November 2024

Simply Wall St.
·
05 Nov 2024

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024

GlobeNewswire
·
01 Nov 2024

UBS launches SMID cap biotechs with cancer, autoimmunity in focus

seekingalpha
·
25 Oct 2024

UBS Initiates Iovance Biotherapeutics With Buy Rating, $17 Price Target

MT Newswires Live
·
24 Oct 2024

Iovance Biotherapeutics Inc : UBS Initiates Coverage With Buy Rating and Target Price $17

THOMSON REUTERS
·
24 Oct 2024

Perceptive Advisors LLC Acquires New Stake in Inhibikase Therapeutics Inc

GuruFocus.com
·
23 Oct 2024

State Street Corp's Strategic Acquisition in Iovance Biotherapeutics Inc

GuruFocus.com
·
18 Oct 2024

Iovance Biotherapeutics call volume above normal and directionally bullish

TIPRANKS
·
18 Oct 2024

Is Iovance Biotherapeutics Inc. (IOVA) the Most Promising Stock to Buy According to Wall Street Analysts?

Insider Monkey
·
17 Oct 2024

Stifel Nicolaus Keeps Their Buy Rating on Iovance Biotherapeutics (IOVA)

TIPRANKS
·
14 Oct 2024

Is Iovance Biotherapeutics, Inc. (IOVA) the Best Growth Stock Under $10 to Buy?

Insider Monkey
·
13 Oct 2024